Nissha Co., Ltd. (hereinafter “the Company”) hereby announces that our consolidated subsidiary Nissha Medical Technologies (hereinafter “NMT”) has acquired the majority equity of Isometric Intermediate LLC on March 1, 2024. Following the acquisition, Isometric Intermediate LLC and its related group companies (hereinafter  “Isometric”) have become subsidiaries of the Company. Isometric utilizes proprietary tooling and process technologies to achieve single micron tolerances of micro injection mold components for medical device and pharmaceutical markets.

The Company and NMT recognize the immense growth potential within the CDMO market for medical devices and have focused our efforts on it as a key area for expansion. Our goal is to expand our pipeline by fortifying and broadening our capabilities to respond to the ever-evolving landscape of medical device innovation, particularly in the realm of minimally invasive surgical instruments, and explore exciting new possibilities in areas like surgical robotics. Through this equity partnership, we offer significant innovation opportunities of medical devices by acquiring Isometric's design for excellence (DfX) capabilities for component miniaturization, as well as processing technologies such as silicone and micro two-shot molding.

*The companies acquiring the equity are Isometric Intermediate LLC and its related group companies. However, to show the scope of the business and the impact of this acquisition on the Company's consolidated operating results, for convenience, an overview of Isometric Holdings, Inc., which is a holding company of them, is provided here.